Official website (https://www.novonesis.com/)
Novonesis
Sign in to saveAlso known as Novo Enzymes A/S, Novozymes A/S, Novonesis A/S
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Key facts
- Company.name
- Novozymes A/S
- Company.trading_name
- Novozymes
- Company.logo
- Novozymes_logo.svg
- Company.image
- Novozymes - hovedbygning Bagsværd.jpg
- Company.logo_size
- 225px
- Company.type
- Aktieselskab
- Company.parent
- Novo Holdings A/S
- Company.fate
- Merged with Chr. Hansen
- Company.successor
- Novonesis
- Company.location
- Bagsværd, Denmark
- Company.industry
- Biotechnology
- Company.products
- Enzymes, microorganisms, biopharmaceutical ingredients
- Company.revenue
- (2022)
- Company.operating_income
- (2022)
- Company.net_income
- (2022)
- Company.assets
- (2022)
- Company.equity
- (2022)
- Company.num_employees
- 6,781 (2022)
via Wikipedia infobox
Research organization · ROR
- Type
- Company, Funder
- Founded
- 2000
- Location
- Copenhagen, Denmark
- Status
- Active
GRID grid.10582.3e · ISNI 0000 0004 0373 0797
Official website
Novonesis | The time for biosolutions is now
Novonesis is a leading global biosolutions company formed through a combination of Chr. Hansen and Novozymes.
novonesis.com →Link to the official site · 11,267 chars · not written by Vinony
Wikidata facts
- Official name
- Novozymes A/S
- Employees
- 6781
- Revenue
- 17553000000
- Official website
- www.novonesis.com
- Image
- Novozymes - hovedbygning Bagsværd.jpg
Show 4 more facts
- inception
- 2000-11-13
- total assets
- 27983000000
- social media followers
- 13934
- Commons category
- Novozymes
Sources (11)
via Wikidata · CC0
~3 min read
Article
4 sectionsContents
- History
- Ownership
- References
- External links
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange.